These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6665759)

  • 21. The thrombolytic activity of streptokinase in the rabbit.
    English PD; Smith RA; Dupe RJ; Green J; Hibbs MJ
    Thromb Haemost; 1981 Aug; 46(2):535-7. PubMed ID: 7302893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Streptokinase and rt-PA activate platelets by a different way: implications on the rethrombosis rate after their administration in myocardial infarction.
    Parise P; Hauert J; Iorio A; Callegari P; Agnelli G
    J Lab Clin Med; 1995 Feb; 125(2):212-21. PubMed ID: 7531212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation of a novel streptokinase mutant with improved stability.
    Shi GY; Chang BI; Su SW; Young KC; Wu DH; Chang LC; Tsai YS; Wu HL
    Thromb Haemost; 1998 May; 79(5):992-7. PubMed ID: 9609235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of plasmin, microplasmin, and streptokinase-plasmin complex for the in vitro degradation of fibronectin and laminin- implications for vitreoretinal surgery.
    Hermel M; Dailey W; Hartzer MK
    Curr Eye Res; 2010 May; 35(5):419-24. PubMed ID: 20450255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A chimeric streptokinase with unexpected fibrinolytic selectivity.
    Goldstein J; Matsueda GR; Shaw SY
    Thromb Haemost; 1996 Sep; 76(3):429-38. PubMed ID: 8883282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery.
    Paganelli F; Alessi MC; Morange P; Maixent JM; Lévy S; Vague IJ
    Thromb Haemost; 1999 Jul; 82(1):104-8. PubMed ID: 10456462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional roles of streptokinase C-terminal flexible peptide in active site formation and substrate recognition in plasminogen activation.
    Zhai P; Wakeham N; Loy JA; Zhang XC
    Biochemistry; 2003 Jan; 42(1):114-20. PubMed ID: 12515545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simplified recombinant plasmin: production and functional comparison of a novel thrombolytic molecule with plasma-derived plasmin.
    Hunt JA; Petteway SR; Scuderi P; Novokhatny V
    Thromb Haemost; 2008 Sep; 100(3):413-9. PubMed ID: 18766256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immobilization of the human plasmin light chain and analysis of its complexes with streptokinase].
    Lezhen TI; Kudinov SA
    Ukr Biokhim Zh (1978); 1983; 55(3):302-6. PubMed ID: 6223427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-species pharmacologic evaluation of plasmin as a direct-acting thrombolytic agent: ex vivo evaluation for large animal model development.
    Landskroner K; Olson N; Jesmok G
    J Vasc Interv Radiol; 2005 Mar; 16(3):369-77. PubMed ID: 15758133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An anti-plasminogen antibody preparation that inhibits the activation of human plasminogen but enhances the activator activity of the B-chain-streptokinase complex.
    Summaria L; Pavlovic B; Sandesara J
    Thromb Res; 1989 Apr; 54(1):1-15. PubMed ID: 2727955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Covalent linkage of streptokinase to recombinant hirudin: a novel thrombolytic agent with antithrombotic properties.
    Phaneuf MD; Ozaki CK; Johnstone MT; Loza JP; Quist WC; LoGerfo FW
    Thromb Haemost; 1994 Apr; 71(4):481-7. PubMed ID: 8052967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LYS-plasminogen shortens the duration of local thrombolytic treatment of peripheral arterial occlusions--a randomized controlled trial.
    Poredos P; Videcnik V
    Wien Klin Wochenschr; 1999 Jan; 111(1):21-5. PubMed ID: 10067266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical trial of China-made recombinant streptokinase in acute myocardial infarction. Collaborative Study Group on Thrombolysis with China-made recombinant streptokinase.
    Chin Med J (Engl); 1997 Jan; 110(1):50-2. PubMed ID: 9594322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Thrombolytics and their use].
    Alessi MC; Juhan-Vague I
    Rev Prat; 1999 Oct; 49(15):1654-8. PubMed ID: 10581996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of activation of human plasminogen by the activator complex, streptokinase-plasmin.
    Gonzalez-Gronow M; Siefring GE; Castellino FJ
    J Biol Chem; 1978 Feb; 253(4):1090-4. PubMed ID: 146709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Binding of an acylated plasminogen activator-streptokinase complex with fibrin and the fibrinolytic response in vitro].
    Aĭsina RB; Zhitkova IuV; Varfolomeev SD
    Vopr Med Khim; 1994; 40(3):31-5. PubMed ID: 8079435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The fibrinolytic system and its activators].
    Seifried E
    Z Gesamte Inn Med; 1993; 48(6-7):272-82. PubMed ID: 8333223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The amidolytic activity of the SK-plasminogen complex is enhanced by a potentiator which is generated in the presence of vascular plasminogen activator--role of fibrin degradation products.
    Soria J; Soria C; Bertrand O; Dunn F; Samama M; Bachmann F
    Thromb Haemost; 1982 Jun; 47(3):193-6. PubMed ID: 7051407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PEGylation of Truncated Streptokinase Leads to Formulation of a Useful Drug with Ameliorated Attributes.
    Sawhney P; Katare K; Sahni G
    PLoS One; 2016; 11(5):e0155831. PubMed ID: 27192220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.